In conclusion, the present findings suggest that TLR4 represents a potential mechanism of PI resistance by controlling mitochondrial fitness and its inhibition could be successful in patients with refractory MM to overcome bortezomib resistance. The gene discussed is TLR4; the disease is Miyoshi myopathy.